130 related articles for article (PubMed ID: 7036504)
1. Glucose metabolism in patients on continuous ambulatory peritoneal dialysis (CAPD).
Lindholm B; Bergström J; Karlander SG
Trans Am Soc Artif Intern Organs; 1981; 27():58-60. PubMed ID: 7036504
[No Abstract] [Full Text] [Related]
2. Glucose tolerance in patients undergoing continuous ambulatory peritoneal dialysis.
Lindholm B; Karlander SG
Acta Med Scand; 1986; 220(5):477-83. PubMed ID: 3544691
[TBL] [Abstract][Full Text] [Related]
3. Continuous ambulatory peritoneal dialysis in diabetes mellitus. The risks and benefits of intraperitoneal insulin.
Madden MA; Zimmerman SW; Simpson DP
Am J Nephrol; 1982; 2(3):133-9. PubMed ID: 6758585
[TBL] [Abstract][Full Text] [Related]
4. [Biochemical changes with continuous ambulant peritoneal dialysis (CAPD)].
Fuchs C; Armstrong VW; Dorn D; Ebert R; Scheler F
Z Urol Nephrol; 1982 Jun; 75(6):415-27. PubMed ID: 6750973
[TBL] [Abstract][Full Text] [Related]
5. Carbohydrate and lipid metabolism during continuous ambulatory peritoneal dialysis (CAPD): the effect of a single dialysis cycle.
Heaton A; Johnston DG; Burrin JM; Orskov H; Ward MK; Alberti KG; Kerr DN
Clin Sci (Lond); 1983 Nov; 65(5):539-45. PubMed ID: 6352157
[TBL] [Abstract][Full Text] [Related]
6. A Comparison Study of Glucose Fluctuation During Automated Peritoneal Dialysis and Continuous Ambulatory Peritoneal Dialysis.
Okada E; Oishi D; Sakurada T; Yasuda T; Shibagaki Y
Adv Perit Dial; 2015; 31():34-7. PubMed ID: 26714386
[TBL] [Abstract][Full Text] [Related]
7. Adaptation of CAPD patients to the continuous peritoneal energy uptake.
von Baeyer H; Gahl GM; Riedinger H; Borowzak R; Averdunk R; Schurig R; Kessel M
Kidney Int; 1983 Jan; 23(1):29-34. PubMed ID: 6339787
[No Abstract] [Full Text] [Related]
8. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
[TBL] [Abstract][Full Text] [Related]
9. [Continuous ambulatory peritoneal dialysis (CAPD)].
Mydlík M; Derzsiová K; Válek A; Takác M
Vnitr Lek; 1982 Jun; 28(6):602-8. PubMed ID: 7112984
[No Abstract] [Full Text] [Related]
10. [Vitamins and continuous ambulatory peritoneal dialysis (CAPD)].
Mydlík M; Derzsiová K; Válek A; Szabó T; Dandár V; Takác M
Cas Lek Cesk; 1983 Aug; 122(34):1046-9. PubMed ID: 6627319
[No Abstract] [Full Text] [Related]
11. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
[TBL] [Abstract][Full Text] [Related]
12. Preliminary experience with continuous ambulatory peritoneal dialysis.
Rahman M; Haq SA; Haq A
Bangladesh Med Res Counc Bull; 1982 Dec; 8(2):52-8. PubMed ID: 7184498
[TBL] [Abstract][Full Text] [Related]
13. Impact of dialysis therapy on insulin resistance in end-stage renal disease: comparison of haemodialysis and continuous ambulatory peritoneal dialysis.
Kobayashi S; Maejima S; Ikeda T; Nagase M
Nephrol Dial Transplant; 2000 Jan; 15(1):65-70. PubMed ID: 10607769
[TBL] [Abstract][Full Text] [Related]
14. Mathematical modeling of the glucose-insulin system during peritoneal dialysis with glucose-based fluids.
Galach M; Waniewski J; Axelsson J; Heimburger O; Werynski A; Lindholm B
ASAIO J; 2011; 57(1):41-7. PubMed ID: 21057307
[TBL] [Abstract][Full Text] [Related]
15. Effect of dialysate glucose load on plasma glucose and glucoregulatory hormones in CAPD patients.
Armstrong VW; Creutzfeldt W; Ebert R; Fuchs C; Hilgers R; Scheler F
Nephron; 1985; 39(2):141-5. PubMed ID: 3883205
[TBL] [Abstract][Full Text] [Related]
16. [Intermittent peritoneal dialysis and continuous ambulatory peritoneal dialysis].
Radovanović Lj; Popović J; Radlović O
Srp Arh Celok Lek; 1988; 116(11-12):967-76. PubMed ID: 3247614
[No Abstract] [Full Text] [Related]
17. Benefits of a continuous ambulatory peritoneal dialysis (CAPD) technique with one icodextrin-containing and two biocompatible glucose-containing dialysates for preservation of residual renal function and biocompatibility in incident CAPD patients.
Yoon HE; Chang YK; Shin SJ; Choi BS; Kim BS; Park CW; Song HC; Yoon SA; Jin DC; Kim YS
J Korean Med Sci; 2014 Sep; 29(9):1217-25. PubMed ID: 25246739
[TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone improves glucose metabolism in nondiabetic uremic patients on CAPD.
Lin SH; Lin YF; Kuo SW; Hsu YJ; Hung YJ
Am J Kidney Dis; 2003 Oct; 42(4):774-80. PubMed ID: 14520628
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of continuous ambulatory peritoneal dialysis (CAPD) in patients of chronic renal failure.
Banerjee S; Ratnu KS
J Assoc Physicians India; 1984 Jun; 32(6):495-8. PubMed ID: 6511726
[No Abstract] [Full Text] [Related]
20. Insulin resistance in dialysis versus non dialysis end stage renal disease patients without diabetes.
Satirapoj B; Supasyndh O; Phantana-Angkul P; Ruangkanchanasetr P; Nata N; Chaiprasert A; Kanjanakul I; Choovichian P
J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S87-93. PubMed ID: 22043573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
